Tag: Hatch-Waxman Act
Generic Patent Case Law: Landmark Court Decisions Shaping Drug Prices
Jul, 28 2026
Explore landmark generic patent case law decisions like Amgen v. Sanofi and Allergan v. Teva. Understand how Hatch-Waxman, Orange Book listings, and IPRs shape drug prices and market entry.
FDA’s Abbreviated New Drug Application Process Explained: How Generic Drugs Get Approved
Mar, 13 2026
The FDA’s Abbreviated New Drug Application (ANDA) process lets generic drug makers prove their products are equivalent to brand-name drugs without repeating costly clinical trials. This system saves billions annually and makes medications affordable for millions.
Hatch-Waxman Act: How It Shaped Generic Drug Approval in the U.S.
Dec, 16 2025
The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with faster market entry. It slashed drug costs, boosted generic use to 90% of prescriptions, but also enabled patent abuses that delay competition.